|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 6, 3639-3647, February 7, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Breast and prostatic carcinomas, melanoma, and
endothelial cell lines are chemoattracted by medium conditioned by
mature osteoblasts. The chemoattractant for endothelial cells was
identified with C3, carboxyl-terminal trimer of pro-collagen type I. We
report that C3 induces directional migration and proliferation, the
expression of tissue inhibitor of metalloproteinases-2,
pro-metalloproteinase-2 and -9, and their activation in MDA MB231
cells, without changing the expression of tissue inhibitor of
metalloproteinases-1 and of metalloproteinase-14. Antiserum against
metalloproteinase-2 or -9 or -14, tissue inhibitor of
metalloproteinases-1, or GM6001 inhibits the C3-induced migration.
Urokinase and its receptor are detected and unchanged upon exposure to
C3. The antibody against urokinase or addition of plasminogen activator
inhibitor inhibits migration. Blocking antibodies to integrins
Pro-collagen I COOH-terminal Trimer Induces Directional Migration
and Metalloproteinases in Breast Cancer Cells*
,
,
,
¶
Genetica, Dipartimento di Oncologia,
Biologia e Genetica, Università di Genova, 26 C. Europa and
§ Istituto per la Ricerca sul Cancro, Viale Benedetto XIV,
Genova 16132, Italy
2,
6,
1, and
3 inhibit chemotaxis and do not change urokinase and
urokinase receptor expression. Blockage of
2,
1, and
3 integrins affect differently the
induction by C3 of pro-metalloproteinase-2 and -9 and of tissue inhibitor of metalloproteinases-2. Chemotaxis to C3 is also inhibited by genistein, by pertussis toxin, which also inhibits
C3-induced pro-metalloproteinase -2 and -9, but not urokinase
expression. Wortmannin partially inhibits C3-induced cell migration.
Other, but not all, breast carcinoma lines tested responded to C3 with migration and pro-metalloproteinase-2 induction. Presently C3 is the
only agent known to induce migration specifically of both endothelial
and breast carcinoma cells. The mitogenic and motogenic role of C3
in vitro might prefigure a role in in
vivo carcinogenesis and in the establishment of metastasis.
*
This work was supported by MUIR grants, Italy, and CNR
Biotecnologie, Italy (to P. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
A. Oganesian, S. Au, J. A. Horst, L. C. Holzhausen, A. J. Macy, J. M. Pace, and P. Bornstein The NH2-terminal Propeptide of Type I Procollagen Acts Intracellularly to Modulate Cell Function J. Biol. Chem., December 15, 2006; 281(50): 38507 - 38518. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Berno, D Porrini, F Castiglioni, M Campiglio, P Casalini, S M Pupa, A Balsari, S Menard, and E Tagliabue The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1 Endocr. Relat. Cancer, June 1, 2005; 12(2): 393 - 406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |